Evaluation of the risk of acute kidney injury with the use of piperacillin/tazobactam among adult critically ill patients

PURPOSE: Piperacillin/tazobactam (PT), when combined with vancomycin, is associated with an increased risk of acute kidney injury (AKI). It is not known whether PT alone is associated with a higher incidence of AKI compared to other β-lactams among critically ill patients. The objective of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Mohamed O., Mohamed, Adham M., Mitwally, Hassan A., Shible, Ahmed A., Ait Hssain, Ali, Abdelaty, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518983/
https://www.ncbi.nlm.nih.gov/pubmed/32700095
http://dx.doi.org/10.1007/s15010-020-01480-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518983/
https://www.ncbi.nlm.nih.gov/pubmed/32700095
http://dx.doi.org/10.1007/s15010-020-01480-x

Ejemplares similares